Home The Word Brain My Amedeo FAQ Privacy About


Hanzi Hunter

Learning 500 Chinese characters in 30 days is possible.

Abstract • About

  Cervical Cancer

  Free Subscription


27.04.2026

1 Anal Sci
1 Ann Surg Oncol
1 Arch Med Res
1 Biochem Biophys Rep
1 Biochem Biophys Res Commun
1 Bioorg Med Chem
4 BMC Cancer
1 BMC Med
1 BMC Public Health
3 BMC Womens Health
1 BMJ Open
3 Brachytherapy
1 Cancer Cell Int
1 Cancer Control
1 Cancer Epidemiol Biomarkers Prev
1 Cancer Med
1 Cancer Radiother
1 Cancer Res Commun
1 Clin Epigenetics
1 Clin Transl Radiat Oncol
1 Commun Med (Lond)
1 Cureus
1 Diagn Cytopathol
1 Eur J Radiol Open
1 Front Cell Dev Biol
1 Front Cell Infect Microbiol
1 Front Immunol
1 Front Oncol
1 Front Pharmacol
2 Geburtshilfe Frauenheilkd
1 Glob Health Action
4 Gynecol Oncol
1 Gynecol Oncol Rep
1 Hereditas
2 Hum Vaccin Immunother
1 In Silico Pharmacol
1 Int J Cancer
1 Int J Clin Oncol
1 Int J Gynaecol Obstet
1 Int J Radiat Oncol Biol Phys
1 Int J Womens Health
1 Ir J Med Sci
1 iScience
1 J Cancer Res Clin Oncol
1 J Dig Dis
1 J Family Med Prim Care
1 J Healthc Sci Humanit
1 J Low Genit Tract Dis
1 J Med Chem
1 J Med Screen
2 J Med Virol
1 J Minim Invasive Gynecol
1 J Natl Cancer Inst Monogr
1 J Virol
1 JCO Glob Oncol
1 Lancet Reg Health Am
1 Magn Reson Imaging
1 Mol Med Rep
1 Nutr Cancer
2 Obstet Gynecol
1 Oncol Lett
1 Oncologist
1 Phys Med Biol
1 PLoS One
1 Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med
1 Reprod Sci
1 Rev Assoc Med Bras (1992)
1 Rev Med Chil
4 Sci Rep
1 Strahlenther Onkol
1 Technol Cancer Res Treat
1 Vaccine
1 Womens Health (Lond)
1 Womens Health Issues


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Anal Sci

  1. LU Y, Qin H, Zhang W, Shi Q, et al
    An integrated microfluidic system for automatic and self-validated analysis of cervical extracellular vesicle markers PD-L1 and ERBB3.
    Anal Sci. 2026;42:299-312.
    PubMed         Abstract available


    Ann Surg Oncol

  2. RASPAGLIESI F, Bogani G, Ditto A, Maggiore ULR, et al
    Revisiting the Concept of Nerve-Sparing Radical Hysterectomy: A Proof-of-Concept Prospective Study From a Cervical Cancer Cohort.
    Ann Surg Oncol. 2026 Apr 19. doi: 10.1245/s10434-026-19671.
    PubMed         Abstract available


    Arch Med Res

  3. DOUBOVA SV, Contreras-Sanchez SE, McClellan SP, Pina-Sanchez P, et al
    Evaluation of the Pilot Human Papillomavirus Self-Sampling Program in Workplaces in Ciudad Juarez, Mexico.
    Arch Med Res. 2026;57:103316.
    PubMed         Abstract available


    Biochem Biophys Rep

  4. CHEN C, Zhao W, Guo M, Wang W, et al
    Comprehensive analysis of mutational signatures and corresponding driver genes in cervical cancer from Xinjiang.
    Biochem Biophys Rep. 2026;46:102591.
    PubMed         Abstract available


    Biochem Biophys Res Commun

  5. ZHU Y, Xu C, Gu X, Tian Y, et al
    Reprogramming NF-kappaB signaling in cervical cancer: Implications for immune microenvironment and therapeutic resistance.
    Biochem Biophys Res Commun. 2026;818:153746.
    PubMed         Abstract available


    Bioorg Med Chem

  6. YIN Y, Song Z, Wang L, Karam S, et al
    Discovery of novel 1,2,4-triazoles derivatives acting as NF1 activators against cervical cancer.
    Bioorg Med Chem. 2026;138:118661.
    PubMed         Abstract available


    BMC Cancer

  7. ZHOU X, Xu H, Fu Y, Nie Q, et al
    Geographic and demographic patterns of cervical cancer in Africa using GLOBOCAN 2022.
    BMC Cancer. 2026 Apr 18. doi: 10.1186/s12885-026-16000.
    PubMed        

  8. LIU X, Liao Y, Liu Y, Huang H, et al
    Molecular markers for cervical cancer prognosis: a prognostic model using stemness-related lncRNAs and functional analysis of EMX2OS.
    BMC Cancer. 2026 Apr 20. doi: 10.1186/s12885-026-16022.
    PubMed        

  9. HUANG S, Wu S, Li Y, Lin Y, et al
    The value of tertiary lymphoid structure on predicting the survival rate of advanced cervical cancer patients.
    BMC Cancer. 2026 Apr 23. doi: 10.1186/s12885-026-16019.
    PubMed        

  10. NYABYENDA EC, Nkurikiyeyezu K, Sylvain MH, Absolomon G, et al
    Image analysis for cervical cancer classification using deep learning techniques.
    BMC Cancer. 2026 Apr 23. doi: 10.1186/s12885-026-16076.
    PubMed        


    BMC Med

  11. LI Y, Lin YF, Cai B, Chen F, et al
    Modelling the epidemic dynamics of HPV among women in China and optimization of ongoing cervical cancer elimination strategies.
    BMC Med. 2026 Apr 22. doi: 10.1186/s12916-026-04881.
    PubMed         Abstract available


    BMC Public Health

  12. DANGE HB, Kana IY, Suleiman HC, Akyala AI, et al
    Cultural and traditional influences on cervical cancer screening uptake in Nigeria and other West African countries.
    BMC Public Health. 2026 Apr 21. doi: 10.1186/s12889-026-27347.
    PubMed         Abstract available


    BMC Womens Health

  13. DELISLE V, Rochaix L, Bardou M, Uuskula A, et al
    Women's preferences for cervical cancer screening methods: a discrete choice experiment in Estonia and France.
    BMC Womens Health. 2026 Apr 22. doi: 10.1186/s12905-026-04478.
    PubMed        

  14. JANOUSKOVA K, Frei J, Mainz D, Papezova K, et al
    The role of the health belief model and HPV self-testing in cervical cancer screening participation in the Czech Republic.
    BMC Womens Health. 2026 Apr 23. doi: 10.1186/s12905-026-04467.
    PubMed        

  15. LI H, Wu M, Xing Y, Li J, et al
    Sacituzumab govitecan combined with tislelizumab as second-line therapy for recurrent or metastatic cervical cancer: a case report and literature review.
    BMC Womens Health. 2026 Apr 22. doi: 10.1186/s12905-026-04481.
    PubMed        


    BMJ Open

  16. LEE-FOON NK, Lofters A, Dias K, Ogilvie GS, et al
    EMPOWHPVR: exploring the factors that impact HPV self-sampling uptake amongst Black women and people with a cervix in Peel region, Ontario - a qualitative study protocol.
    BMJ Open. 2026;16:e110930.
    PubMed         Abstract available


    Brachytherapy

  17. GROSS A, Wu X, Wang M, Podder T, et al
    Improving complex brachytherapy efficiency: Multidisciplinary quality assurance and workflow optimization.
    Brachytherapy. 2026;25:445-454.
    PubMed         Abstract available

  18. FALLONE CJ, Frick MJ, Golestani A, Cho D, et al
    Assessment of geometric distortions and dosimetric impact from implementing 2D-T2-PROPELLER and 3D-T1-LAVA-FLEX in an MRI-only gynecological brachytherapy workflow.
    Brachytherapy. 2026;25:486-500.
    PubMed         Abstract available

  19. CECEN S, Ozkan E
    G8 score predicts survival in elderly women undergoing vaginal brachytherapy: A retrospective cohort study.
    Brachytherapy. 2026;25:438-444.
    PubMed         Abstract available


    Cancer Cell Int

  20. OUYANG S, Xiong K, Chen P, Liu X, et al
    Correction: Mechanism of interaction between ANXA6 and cGAS to regulate STING signaling pathway and promote ferroptosis in cervical cancer.
    Cancer Cell Int. 2026;26:176.
    PubMed        


    Cancer Control

  21. NIU E, Nicolau IA, Olthof E, de Kok IMCM, et al
    Trends in the Incidence of Human Papillomavirus-Related Cancers in Canada and the Netherlands.
    Cancer Control. 2026;33:10732748261445046.
    PubMed         Abstract available


    Cancer Epidemiol Biomarkers Prev

  22. VASQUEZ GUZMAN CE, Hodes T, Lucas JA, Leslie V, et al
    Cervical Cancer Screening and Prevention among Latinas in the U.S. among a Network of Community Health Centers.
    Cancer Epidemiol Biomarkers Prev. 2026.
    PubMed         Abstract available


    Cancer Med

  23. HUANG CB, Liao GD, Zhang SK, Zeng X, et al
    Risk of 3-Year Cytological Progression by Baseline HPV Status Among Women With Normal Cytology: A Multicenter Cohort Study.
    Cancer Med. 2026;15:e71855.
    PubMed         Abstract available


    Cancer Radiother

  24. CHARGARI C, Ducassou A, Laville A, Lucia F, et al
    Corrigendum to 'Radiotherapy and brachytherapy for cervical cancer : Recommendations of the Societe francaise de radiotherapie oncologique' [Cancer Radiother 29 (2025) 104753].
    Cancer Radiother. 2026;30:104799.
    PubMed        


    Cancer Res Commun

  25. VANG AP, Quino JE, Rolon AM, Morales Arana A, et al
    Capturing Latino Health Disparities: Lessons from Mail- and Community-Based Population Health Surveys in California.
    Cancer Res Commun. 2026;6:873-883.
    PubMed         Abstract available


    Clin Epigenetics

  26. FAN G, Xiaolu Y, Keremu Y, Weina K, et al
    Effectiveness analysis and clinical application potential exploration of combined detection of PAX1/JAM3 gene methylation in early diagnosis of cervical precancerous lesions.
    Clin Epigenetics. 2026;18:73.
    PubMed         Abstract available


    Clin Transl Radiat Oncol

  27. ZIDANE P, Berger T, Boros A, Caraivan I, et al
    Early tumor shrinkage correlates with final EBRT response in cervical cancer patients treated with MRI-guided radiotherapy.
    Clin Transl Radiat Oncol. 2026;59:101158.
    PubMed         Abstract available


    Commun Med (Lond)

  28. WU X, Wang D, Wang J, Huang Y, et al
    Fruquintinib plus sintilimab in advanced cervical cancer: an open-label, multicentre, phase 2 study.
    Commun Med (Lond). 2026 Apr 21. doi: 10.1038/s43856-026-01572.
    PubMed         Abstract available


    Cureus

  29. RAMIDI GR, Yadav R, Sunny G, Patnaik A, et al
    Low-Dose Metronomic Chemotherapy With Fixed Low-Dose Nivolumab for Recurrent Cervical Cancer After Radiotherapy: Experience From Routine Clinical Practice.
    Cureus. 2026;18:e105439.
    PubMed         Abstract available


    Diagn Cytopathol

  30. OLSON K, Kucher E, Rasmussen A, Selvaggi SM, et al
    Unsatisfactory ThinPrep Pap Tests: An Educational Approach to Quality.
    Diagn Cytopathol. 2026;54:444-448.
    PubMed         Abstract available


    Eur J Radiol Open

  31. HAKIM PK, Zeinalkhani F, Alaeddini S, Mohammadzadeh S, et al
    Diagnostic utility of apparent diffusion coefficient values in cervical cancer staging: A retrospective study.
    Eur J Radiol Open. 2026;16:100744.
    PubMed         Abstract available


    Front Cell Dev Biol

  32. HE Z, Hao H, Li X, Ji Y, et al
    The role of long non-coding RNAs in therapy resistance of cervical cancer and therapeutic potential.
    Front Cell Dev Biol. 2026;14:1746979.
    PubMed         Abstract available


    Front Cell Infect Microbiol

  33. KHAN SU, Halawi MH, Almehmadi M, Taha R, et al
    Innate immune recognition and microenvironmental reprogramming in HPV-induced cervical cancer: from pattern recognition receptor activation to immune tolerance disruption.
    Front Cell Infect Microbiol. 2026;16:1758873.
    PubMed         Abstract available


    Front Immunol

  34. ZHAO L, Zhai Q, Zhang W, Wen L, et al
    Favorable short-term survival in locally advanced cervical cancer with optimal pathological response after neoadjuvant chemoimmunotherapy: a real-world analysis.
    Front Immunol. 2026;17:1737081.
    PubMed         Abstract available


    Front Oncol

  35. HE Y, Lu Y, Hu L
    Radiomics and artificial intelligence in precision radiotherapy for cervical cancer: a narrative review.
    Front Oncol. 2026;16:1781422.
    PubMed         Abstract available


    Front Pharmacol

  36. SUN ZY, Xu J, Wei W
    Optimized ultrasound extraction and cytotoxic activity against HeLa cervical cancer cells of total flavonoids of Physochlaina physaloides (L.) G. Don.
    Front Pharmacol. 2026;17:1800105.
    PubMed         Abstract available


    Geburtshilfe Frauenheilkd

  37. LOHNER A, Muller V, Baehr A, Krug D, et al
    INTERLACE Study: Real-world Data for Germany Based on a Case Series of Patients with Locally Advanced Cervical Cancer.
    Geburtshilfe Frauenheilkd. 2026;86:376-381.
    PubMed         Abstract available

  38. HENES M, Mann E, Hirchenhain C, Kentner A, et al
    Registry Study of the Working Group on Cervical Pathology and Colposcopy (AGCPC) on the Diagnostic Algorithm for the New Cervical Cancer Screening - Persistent HPV Infections and Squamous Cell Lesions: Evaluation of over 10000 Patients.
    Geburtshilfe Frauenheilkd. 2026;86:382-394.
    PubMed         Abstract available


    Glob Health Action

  39. KOLAHDOOZ F, Jang SL, Yi KJ, Deck S, et al
    Barriers and facilitators to the utilization of cancer screening services in two Arctic Indigenous communities in Canada.
    Glob Health Action. 2026;19:2657081.
    PubMed         Abstract available


    Gynecol Oncol

  40. OGASAWARA A, Suzuki S, Oda K, Yunokawa M, et al
    Phase II study of pembrolizumab plus olaparib in recurrent cervical cancer progressing after platinum-based chemotherapy (GOTIC-025).
    Gynecol Oncol. 2026;208:122-130.
    PubMed         Abstract available

  41. KIM JH, Hwang WY, Choi CH, Kim HS, et al
    Oncologic outcomes and the impact of minimally invasive surgery in early-stage cervical cancer patients undergoing radical trachelectomy: A retrospective multicenter cohort study from the Korean Gynecologic Oncology Group Study (KGOG 1048).
    Gynecol Oncol. 2026;208:113-121.
    PubMed         Abstract available

  42. ROTHNIE K, Tristano E, Diaz-Rodriguez M, Filippova O, et al
    Expanded subtype testing for circulating tumor HPV DNA reliably detects the presence of advanced-stage cervical cancer.
    Gynecol Oncol. 2026;207S:47-52.
    PubMed         Abstract available

  43. VAN NIEUWENHUYSEN E, Vergote I, Randall LM, Tromp J, et al
    Tisotumab vedotin plus carboplatin or pembrolizumab in recurrent or metastatic cervical cancer: 5-year results from the innovaTV 205/ENGOT-cx8/GOG-3024 study.
    Gynecol Oncol. 2026;207S:3-13.
    PubMed         Abstract available


    Gynecol Oncol Rep

  44. TOSCANO FP, Cipullo LMA, Rispoli AI, Curcio B, et al
    Low-volume nodal disease in early-stage cervical cancer: a case report of favorable outcome without adjuvant therapy.
    Gynecol Oncol Rep. 2026;64:102077.
    PubMed         Abstract available


    Hereditas

  45. LAN D, Sun X, Yao L, Cao B, et al
    miR-1229-3p promotes epithelial-mesenchymal transition and metastasis of cervical cancer cells by targeting FBXL5.
    Hereditas. 2026 Apr 22. doi: 10.1186/s41065-026-00679.
    PubMed        


    Hum Vaccin Immunother

  46. XU M, Qiu S, Zhou J, Zhang Y, et al
    Ivonescimab combined with chemotherapy for the treatment of metastatic cervical cancer: A case report and literature review.
    Hum Vaccin Immunother. 2026;22:2632451.
    PubMed         Abstract available

  47. SABALE U, Cherif A, Valente S, Cook J, et al
    Estimating the age distribution of disease-causal HPV infection in women with high-grade cervical intraepithelial neoplasia in Denmark, Estonia, Norway, Slovenia, and Sweden: A modeling study.
    Hum Vaccin Immunother. 2026;22:2651503.
    PubMed         Abstract available


    In Silico Pharmacol

  48. HARISHKUMAR SD, Pasha S, Harendra B, Dharmashekar C, et al
    Piceid as a promising candidate for multi-target adjunctive therapeutic for inflammation-associated cervical cancer progression: an in silico approach.
    In Silico Pharmacol. 2026;14:117.
    PubMed         Abstract available


    Int J Cancer

  49. SCHROLL JB, Bonde J, Lynge E, Waldstrom M, et al
    Health care policy trial of primary human papillomavirus-based cervical screening in Denmark: Comparison of three triage algorithms.
    Int J Cancer. 2026;158:3197-3207.
    PubMed         Abstract available


    Int J Clin Oncol

  50. YOKOI A, Machida H, Okazawa-Sakai M, Nishino K, et al
    Optimal adjuvant strategy in intermediate-risk cervical cancer: a systematic review and meta-analysis.
    Int J Clin Oncol. 2026 Apr 21. doi: 10.1007/s10147-026-03028.
    PubMed         Abstract available


    Int J Gynaecol Obstet

  51. ZHU A, Ma Y, Chen F, Zhou L, et al
    Clinicopathologic characteristics and prognostic outcomes of surgically treated neuroendocrine cervical carcinoma: A single institution retrospective analysis.
    Int J Gynaecol Obstet. 2025 Nov 27. doi: 10.1002/ijgo.70697.
    PubMed         Abstract available


    Int J Radiat Oncol Biol Phys

  52. HOUDOU L, Bruand M, Laroze S, Annede P, et al
    UNICURE-HD: A Multicentric retrospective cohort study of Single-Insertion Image-Guided HDR Brachytherapy for Locally Advanced Cervical Cancer in the context of Limited Brachytherapy access in France.
    Int J Radiat Oncol Biol Phys. 2026 Apr 18:S0360-3016(26)00598.
    PubMed         Abstract available


    Int J Womens Health

  53. DARVISHALI MH, Nikkhah H, Rahavi H, Jalali H, et al
    HPV Genotypes and Survival Outcomes in Invasive Cervical Cancer: A Retrospective Molecular Analysis of FFPE Clinical Samples in an Iranian Cohort.
    Int J Womens Health. 2026;18:589530.
    PubMed         Abstract available


    Ir J Med Sci

  54. LU Y, Yuan Y, Liang S
    miR-1307-3p promotes the progression of cervical cancer by targeting FOXO3.
    Ir J Med Sci. 2026 Apr 23. doi: 10.1007/s11845-026-04372.
    PubMed        


    iScience

  55. YANG H, Li W, Zhang H, Liu Y, et al
    pH-responsive Folate-PEG modified ZIF-8 Nanoparticles deliver fisetin to Aquaporin-3 for cervical cancer therapy.
    iScience. 2026;29:115521.
    PubMed         Abstract available


    J Cancer Res Clin Oncol

  56. SHUQIAN Z, Zhi C, Ain Q, Yan L, et al
    LncRNA-LINC01281 exerts anti-cancer functions via the MYC/VEGF pathway in the progression of cervical cancer.
    J Cancer Res Clin Oncol. 2026;152:93.
    PubMed        


    J Dig Dis

  57. SHEN X, Li SB, Gao MJ, Cao JJ, et al
    Relationship Between Fecal Bile Acid Profile and Intestinal Microbiota in Patients With Chronic Radiation Enteritis.
    J Dig Dis. 2026;27.
    PubMed         Abstract available


    J Family Med Prim Care

  58. ALDEYAIN SJ, Alkhulaifi NS, Almutairi FM, Alenezi RS, et al
    Knowledge, attitudes and practice toward cervical cancer and its screening among women in Kuwait: A cross-sectional study.
    J Family Med Prim Care. 2026;15:750-755.
    PubMed         Abstract available


    J Healthc Sci Humanit

  59. NOBLE E, Webb L, Abdalla E
    Evaluation of the Impact of Cervical Cancer and HPV Educational Awareness Program in Macon County, Alabama from 2018 to 2023.
    J Healthc Sci Humanit. 2025;15:120-145.
    PubMed         Abstract available


    J Low Genit Tract Dis

  60. RODRIGUEZ D, Fonseca T, King TS, Moreno M, et al
    Cervical Cancer Screening Patterns and Outcomes in Women Over 65 Years Old: A Retrospective Study of Medicare Patients.
    J Low Genit Tract Dis. 2026 Apr 23. doi: 10.1097/LGT.0000000000000958.
    PubMed         Abstract available


    J Med Chem

  61. ZENG H, Qiu B, Yang J, Xie Y, et al
    Design, Synthesis and Biological Evaluation of 6H-Benzimidazo[1',2':1,2]pyrido[3,4-b]indole Derivatives as TDP1 Inhibitors: Potent Synergistic Agents with Topotecan against Cervical Cancer.
    J Med Chem. 2026 Apr 21. doi: 10.1021/acs.jmedchem.6c00016.
    PubMed         Abstract available


    J Med Screen

  62. DARVISHIAN M, Moustaqim-Barrette A, Awadalla P, Bhatti P, et al
    Provincial variation and associated factors in adherence to cervical cancer screening in Canada: Evidence from the Canadian Partnership for Tomorrow's Health.
    J Med Screen. 2026 Apr 24:9691413261445025. doi: 10.1177/09691413261445025.
    PubMed         Abstract available


    J Med Virol

  63. ABUDUXIKUER G, Abulimiti T, Abudurexiti G, Zhuo Q, et al
    Population-Based Evaluation of a Novel E6/E7 Immunocytochemistry Assay for Cervical Cancer Screening and Triage of HPV-Positive Women.
    J Med Virol. 2026;98:e70922.
    PubMed         Abstract available

  64. NKADI EH, Schaal DL, Scott RS
    Epstein-Barr Virus and Human Papillomavirus Co-Infections in Epithelial Carcinomas.
    J Med Virol. 2026;98:e70935.
    PubMed         Abstract available


    J Minim Invasive Gynecol

  65. SHI G, Xiao Y, Han L, Zhao W, et al
    Impact of Prior Conization on Oncological Outcomes of Laparoscopic versus Open Radical Hysterectomy in Early-Stage Cervical Cancer: A Propensity Score-Weighted Retrospective Observational Study.
    J Minim Invasive Gynecol. 2026 Apr 18:S1553-4650(26)00240.
    PubMed         Abstract available


    J Natl Cancer Inst Monogr

  66. CHANDRAN A, Togawa K, Mosquera I, Selmouni F, et al
    From evidence to action: the IARC's role in strengthening cancer prevention and early detection.
    J Natl Cancer Inst Monogr. 2026;2026:69-77.
    PubMed         Abstract available


    J Virol

  67. GRACE M, Beeravolu H, Alhamshari A, Skelin J, et al
    Characterization of patient-derived HPV16 E6 and E7 variant alleles.
    J Virol. 2026;100:e0023626.
    PubMed         Abstract available


    JCO Glob Oncol

  68. BENARBIA M, Boukerche A
    Comparative Outcomes of Survival and Relapse After High-Dose-Rate Brachytherapy Versus External-Beam Radiotherapy Boost Following Concurrent Chemoradiation in Locally Advanced Cervical Cancer in Algeria.
    JCO Glob Oncol. 2026;12:e2500664.
    PubMed         Abstract available


    Lancet Reg Health Am

  69. DE BONDT DD, Simms KT, Naslazi E, Killen J, et al
    Optimal cervical cancer screening strategies for unvaccinated and HPV-vaccinated cohorts in the United States: a comprehensive comparative modeling analysis.
    Lancet Reg Health Am. 2026;58:101474.
    PubMed         Abstract available


    Magn Reson Imaging

  70. RODRIGUEZ-SOTO AE, Conlin C, Zuo J, Ebrahimi S, et al
    Development and evaluation of a cervical cancer-specific restriction spectrum imaging (RSI) model.
    Magn Reson Imaging. 2026 Apr 16:110692. doi: 10.1016/j.mri.2026.110692.
    PubMed         Abstract available


    Mol Med Rep

  71. WEI W, Liu C
    [Retracted] Prognostic and predictive roles of microRNA?411 and its target STK17A in evaluating radiotherapy efficacy and their effects on cell migration and invasion via the p53 signaling pathway in cervical cancer.
    Mol Med Rep. 2026;33:176.
    PubMed         Abstract available


    Nutr Cancer

  72. LUVIAN-MORALES J, Galvan-Cota LD, Galvan-Cota LD, Castro-Eguiluz D, et al
    Comparison of Two Instruments to Assess the Impact of Cachexia on Quality of Life in Women with Cervical Cancer.
    Nutr Cancer. 2026 Apr 22:1-13. doi: 10.1080/01635581.2026.2658765.
    PubMed         Abstract available


    Obstet Gynecol


  73. Screening for Cervical Cancer.
    Obstet Gynecol. 2026 Apr 24. doi: 10.1097/AOG.0000000000006257.
    PubMed         Abstract available

  74. VOSOONEY A, Witkop CT, Cantor AG, Nelson HD, et al
    Screening for Cervical Cancer: A Recommendation From the Women's Preventive Services Initiative.
    Obstet Gynecol. 2026 Apr 23. doi: 10.1097/AOG.0000000000006315.
    PubMed         Abstract available


    Oncol Lett

  75. LI X, Wang D
    Role of mesenchymal stem cells and their derived exosomes in cervical cancer: Bidirectional mechanisms and research progress (Review).
    Oncol Lett. 2026;31:225.
    PubMed         Abstract available


    Oncologist

  76. LI Y, Han J, Xiao S, Zhong S, et al
    Prognostic Utility of Systemic Immune-Inflammation Markers in Locally Advanced Cervical Cancer Undergoing Radical Radiotherapy.
    Oncologist. 2026 Apr 21:oyag139. doi: 10.1093.
    PubMed         Abstract available


    Phys Med Biol

  77. QI M, Liu J, Li S, Chang Y, et al
    A fast dosimetric optimization method of intensity modulated brachytherapy(IMBT) treatment plans for cervical cancer.
    Phys Med Biol. 2026 Apr 22. doi: 10.1088/1361-6560.
    PubMed         Abstract available


    PLoS One

  78. WHOP LJ, Mitchell LE, Butler TL, Wong D, et al
    Screen Your Way Study Protocol: Embedding community driven models to increase cervical screening via HPV self-collection to improve cervical cancer outcomes for Aboriginal and Torres Strait Islander people.
    PLoS One. 2026;21:e0336004.
    PubMed         Abstract available


    Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med

  79. KARATAEV CAPITAL EM, CYRILLICC, Zhumabaev AR, Azhimamatova ZT, Ryspekova CD, et al
    [THE INDICATORS OF MORBIDITY, MORTALITY, ONE-YEAR LETHALITY AND DESOLATION OF PATIENTS WITH CERVICAL CANCER IN THE OSH OBLAST OF THE KYRGYZ REPUBLIC].
    Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med. 2026;34:318-321.
    PubMed         Abstract available


    Reprod Sci

  80. BAO Q, Wang Z, Gu G, Wang W, et al
    CD8(+) T Cells in Association with SCD1 Regulate Cervical Cancer and Tumour Microenvironment Correlation Research.
    Reprod Sci. 2026 Apr 22. doi: 10.1007/s43032-026-02070.
    PubMed        


    Rev Assoc Med Bras (1992)

  81. OZBEY G, Aytac S
    A multimodal scanning electron microscopy-atomic force microscopy images for early cervical cancer detection using discrete wavelet transform-derived features and divergence-based classification.
    Rev Assoc Med Bras (1992). 2026;72:e20251173.
    PubMed         Abstract available


    Rev Med Chil

  82. LAVANDEROS S, Valenzuela-Rocuant A, Moraga-Arias B, Ramirez-Faure L, et al
    [Trends in Cervical Cancer Screening Coverage Through Papanicolaou Smear. Chile, 2002-2023].
    Rev Med Chil. 2026;154:171-182.
    PubMed         Abstract available


    Sci Rep

  83. ZHAO M, Liu P, Sun C, Luo F, et al
    Dysregulation of cholesterol metabolism decreases cervical cancer cells' migratory ability caused by propofol in vitro.
    Sci Rep. 2026 Apr 21. doi: 10.1038/s41598-026-49591.
    PubMed        

  84. ZHANG C, Zhao Z, Shi D
    LncRNA CXCL8-203 down-regulates IL-8 and enhance the radiosensitivity of Siha cells in cervical cancer.
    Sci Rep. 2026 Apr 22. doi: 10.1038/s41598-026-49502.
    PubMed        

  85. TRISHA S, Balaji R
    GC-MS guided phytochemical profiling of Bauhinia tomentosa flowers: molecular docking against HPV-E6 and p53 in cervical cancer.
    Sci Rep. 2026 Apr 22. doi: 10.1038/s41598-026-40361.
    PubMed        

  86. ELI AV, Kasten BB, Hartman Y, Wodeyar AM, et al
    Harnessing Id1 as a biomarker in a plasmid reporter system for cervical cancer.
    Sci Rep. 2026 Apr 19. doi: 10.1038/s41598-026-49073.
    PubMed        


    Strahlenther Onkol

  87. SALAZAR-ZUNIGA B, Thurner L, Mohr T, Staber P, et al
    Hemophagocytic lymphohistiocytosis induced by radio-chemo-immunotherapy: a case report.
    Strahlenther Onkol. 2026;202:539-543.
    PubMed         Abstract available


    Technol Cancer Res Treat

  88. ZENG Z, Yang X, Wang W, Liu X, et al
    Effect of Cisplatin Cycles on Prognosis for Cervical Cancer Patients Treated With Concurrent Chemoradiotherapy: A Retrospective Cohort Study.
    Technol Cancer Res Treat. 2026;25:15330338261446498.
    PubMed         Abstract available


    Vaccine

  89. COORAY U, Singh A, Peres MA
    Long-term impacts of HPV vaccination strategies on HPV related Cancer burden among Singaporean female population: A prospective simulation using proportional multistate lifetables.
    Vaccine. 2026;80:128513.
    PubMed         Abstract available


    Womens Health (Lond)

  90. GINGLES J, Zou Y, Chinula L, Tang JH, et al
    Persistent human papillomavirus after thermal ablation in Malawian women with and without HIV: Implications for risk-based cervical cancer prevention in low- and middle-income countries.
    Womens Health (Lond). 2026;22:17455057261428547.
    PubMed         Abstract available


    Womens Health Issues

  91. HALL KC, Stewart MW, Risley C, Reaves S, et al
    Individual and Geographical Factors Associated With Follow-Up Care After an Abnormal Cervical Cancer Screening Result.
    Womens Health Issues. 2026 Apr 18:S1049-3867(26)00043.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum